315 related articles for article (PubMed ID: 33066143)
1. Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential.
Martín Moyano P; Němec V; Paruch K
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066143
[TBL] [Abstract][Full Text] [Related]
2. The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
Tam BY; Chiu K; Chung H; Bossard C; Nguyen JD; Creger E; Eastman BW; Mak CC; Ibanez M; Ghias A; Cahiwat J; Do L; Cho S; Nguyen J; Deshmukh V; Stewart J; Chen CW; Barroga C; Dellamary L; Kc SK; Phalen TJ; Hood J; Cha S; Yazici Y
Cancer Lett; 2020 Mar; 473():186-197. PubMed ID: 31560935
[TBL] [Abstract][Full Text] [Related]
3. Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors.
Murai A; Ebara S; Sasaki S; Ohashi T; Miyazaki T; Nomura T; Araki S
PLoS One; 2020; 15(10):e0240718. PubMed ID: 33064779
[TBL] [Abstract][Full Text] [Related]
4. CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.
Funnell T; Tasaki S; Oloumi A; Araki S; Kong E; Yap D; Nakayama Y; Hughes CS; Cheng SG; Tozaki H; Iwatani M; Sasaki S; Ohashi T; Miyazaki T; Morishita N; Morishita D; Ogasawara-Shimizu M; Ohori M; Nakao S; Karashima M; Sano M; Murai A; Nomura T; Uchiyama N; Kawamoto T; Hara R; Nakanishi O; Shumansky K; Rosner J; Wan A; McKinney S; Morin GB; Nakanishi A; Shah S; Toyoshiba H; Aparicio S
Nat Commun; 2017 Feb; 8(1):7. PubMed ID: 28232751
[TBL] [Abstract][Full Text] [Related]
5. Benzobisthiazoles Represent a Novel Scaffold for Kinase Inhibitors of CLK Family Members.
Prak K; Kriston-Vizi J; Chan AW; Luft C; Costa JR; Pengo N; Ketteler R
Biochemistry; 2016 Jan; 55(3):608-17. PubMed ID: 26701387
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing.
Araki S; Dairiki R; Nakayama Y; Murai A; Miyashita R; Iwatani M; Nomura T; Nakanishi O
PLoS One; 2015; 10(1):e0116929. PubMed ID: 25581376
[TBL] [Abstract][Full Text] [Related]
7. Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions.
Qin Z; Qin L; Feng X; Li Z; Bian J
J Med Chem; 2021 Sep; 64(18):13191-13211. PubMed ID: 34519506
[TBL] [Abstract][Full Text] [Related]
8. Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.
Jain P; Karthikeyan C; Moorthy NS; Waiker DK; Jain AK; Trivedi P
Curr Drug Targets; 2014 May; 15(5):539-50. PubMed ID: 24568585
[TBL] [Abstract][Full Text] [Related]
9. Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases.
Loaëc N; Attanasio E; Villiers B; Durieu E; Tahtouh T; Cam M; Davis RA; Alencar A; Roué M; Bourguet-Kondracki ML; Proksch P; Limanton E; Guiheneuf S; Carreaux F; Bazureau JP; Klautau M; Meijer L
Mar Drugs; 2017 Oct; 15(10):. PubMed ID: 29039762
[TBL] [Abstract][Full Text] [Related]
10. Temperature does matter-an additional dimension in kinase inhibitor development.
Strauch M; Heyd F
FEBS J; 2021 May; 288(10):3148-3153. PubMed ID: 32946682
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.
Iwai K; Yaguchi M; Nishimura K; Yamamoto Y; Tamura T; Nakata D; Dairiki R; Kawakita Y; Mizojiri R; Ito Y; Asano M; Maezaki H; Nakayama Y; Kaishima M; Hayashi K; Teratani M; Miyakawa S; Iwatani M; Miyamoto M; Klein MG; Lane W; Snell G; Tjhen R; He X; Pulukuri S; Nomura T
EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29769258
[TBL] [Abstract][Full Text] [Related]
12. Discovery and optimization of a novel series of Dyrk1B kinase inhibitors to explore a MEK resistance hypothesis.
Kettle JG; Ballard P; Bardelle C; Cockerill M; Colclough N; Critchlow SE; Debreczeni J; Fairley G; Fillery S; Graham MA; Goodwin L; Guichard S; Hudson K; Ward RA; Whittaker D
J Med Chem; 2015 Mar; 58(6):2834-44. PubMed ID: 25738750
[TBL] [Abstract][Full Text] [Related]
13. Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases.
Schmidt M; Rohe A; Platzer C; Najjar A; Erdmann F; Sippl W
Molecules; 2017 Nov; 22(12):. PubMed ID: 29168755
[TBL] [Abstract][Full Text] [Related]
14. Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins.
ElHady AK; Abdel-Halim M; Abadi AH; Engel M
J Med Chem; 2017 Jul; 60(13):5377-5391. PubMed ID: 28561591
[TBL] [Abstract][Full Text] [Related]
15. Identification of CLK1 Inhibitors by a Fragment-linking Based Virtual Screening.
Walter A; Chaikuad A; Loaëc N; Preu L; Knapp S; Meijer L; Kunick C; Koch O
Mol Inform; 2017 Apr; 36(4):. PubMed ID: 28000414
[TBL] [Abstract][Full Text] [Related]
16. 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A.
Falke H; Chaikuad A; Becker A; Loaëc N; Lozach O; Abu Jhaisha S; Becker W; Jones PG; Preu L; Baumann K; Knapp S; Meijer L; Kunick C
J Med Chem; 2015 Apr; 58(7):3131-43. PubMed ID: 25730262
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
18. Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype.
Walter A; Chaikuad A; Helmer R; Loaëc N; Preu L; Ott I; Knapp S; Meijer L; Kunick C
PLoS One; 2018; 13(5):e0196761. PubMed ID: 29723265
[TBL] [Abstract][Full Text] [Related]
19. Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview.
Lindberg MF; Meijer L
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205123
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of alternative splicing by a newly developed inhibitor of Clks.
Muraki M; Ohkawara B; Hosoya T; Onogi H; Koizumi J; Koizumi T; Sumi K; Yomoda J; Murray MV; Kimura H; Furuichi K; Shibuya H; Krainer AR; Suzuki M; Hagiwara M
J Biol Chem; 2004 Jun; 279(23):24246-54. PubMed ID: 15010457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
